Literature DB >> 33443391

Orthopaedic Manifestations of Amyloidosis.

Dafang Zhang1, Melvin C Makhni, James D Kang, Philip Blazar.   

Abstract

Amyloidosis is a disorder of misfolded proteins in human tissues, which can result in morbid cardiac and neurological disease. Historically, the utility of tissue biopsy during orthopaedic procedures to detect amyloidosis has been limited because no disease-modifying therapies were available; however, new drug therapies have recently emerged for the treatment of amyloidosis. Although these novel pharmaceuticals show promise for slowing disease progression, they are primarily effective in the early stages of amyloidosis, underscoring the importance of early diagnosis. Common orthopaedic manifestations of amyloidosis include carpal tunnel syndrome, trigger finger, spontaneous distal biceps tendon rupture, rotator cuff disease, and lumbar spinal stenosis. Carpal tunnel syndrome is frequently the earliest manifestation of amyloidosis, on average preceding a formal diagnosis of amyloidosis by over four years. By recognizing the constellation of musculoskeletal symptoms in the patient with amyloidosis, orthopaedic surgeons can play an active role in patient referral, early detection of systemic disease, and prompt initiation of disease-modifying treatment. There may be a role for selective biopsy for amyloid deposition in at-risk patients during routine orthopaedic procedures.
Copyright © 2021 by the American Academy of Orthopaedic Surgeons.

Entities:  

Year:  2021        PMID: 33443391     DOI: 10.5435/JAAOS-D-20-01146

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  2 in total

1.  Amyloidosis of the Femoral Neck: An Unusual Cause of Pathologic Fracture.

Authors:  Christopher A Worgul; David M Freccero
Journal:  Arthroplast Today       Date:  2022-05-30

Review 2.  Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis.

Authors:  Christopher E Jensen; Mirnela Byku; Gerald A Hladik; Koyal Jain; Rebecca E Traub; Sascha A Tuchman
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.